Search research articles
Contact Us
Filters
Showing results (211-220 of 254) with videos related to
Page
of 26
Sort By:
Current Molecular Pharmacology
|
August 18, 2015
Structure, Function and Metabolism of Hepatic and Adipose Tissue Lipid Droplets: Implications in Alcoholic Liver Disease
Sathish Kumar Natarajan, Karuna Rasineni, Murali Ganesan, et al.
Oncogene
|
June 22, 2010
GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis
S Kurita, J L Mott, L L Almada, et al.
Cancers
|
April 3, 2021
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
John M Rieth, Umang Swami, Sarah L Mott, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
January 29, 2020
Survival after reoperation for recurrent glioblastoma
Royce W Woodroffe, Mario Zanaty, Neetu Soni, et al.
Translational Andrology and Urology
|
August 9, 2023
Retrospective study of testosterone deficiency and symptom burden in patients with pancreatic cancer
Austin G Kazarian, Holly K Conger, Sarah L Mott, et al.
International Journal of Oncology
|
November 12, 2014
TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
Pavla Brachova, Samuel R Mueting, Matthew J Carlson, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
December 14, 2020
Is the age of cervical cancer diagnosis changing over time?
Colette M Gnade, Emily K Hill, Hannah E Botkin, et al.
Plos One
|
March 12, 2019
Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma
Katelynn Davis, Craig D Dunseth, Sarah L Mott, et al.
Journal of Lower Genital Tract Disease
|
September 4, 2020
Effect of Obesity on Cervical Cancer Screening and Outcomes
Colette M Gnade, Emily K Hill, Hannah E Botkin, et al.
Theranostics
|
September 15, 2018
Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness
Ying Xie, Yazhe Wang, Jing Li, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 254) with videos related to
Sort By:
Page
of 26
Current Molecular Pharmacology
|
August 18, 2015
Structure, Function and Metabolism of Hepatic and Adipose Tissue Lipid Droplets: Implications in Alcoholic Liver Disease
Sathish Kumar Natarajan, Karuna Rasineni, Murali Ganesan, et al.
Oncogene
|
June 22, 2010
GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis
S Kurita, J L Mott, L L Almada, et al.
Cancers
|
April 3, 2021
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
John M Rieth, Umang Swami, Sarah L Mott, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
January 29, 2020
Survival after reoperation for recurrent glioblastoma
Royce W Woodroffe, Mario Zanaty, Neetu Soni, et al.
Translational Andrology and Urology
|
August 9, 2023
Retrospective study of testosterone deficiency and symptom burden in patients with pancreatic cancer
Austin G Kazarian, Holly K Conger, Sarah L Mott, et al.
International Journal of Oncology
|
November 12, 2014
TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
Pavla Brachova, Samuel R Mueting, Matthew J Carlson, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
December 14, 2020
Is the age of cervical cancer diagnosis changing over time?
Colette M Gnade, Emily K Hill, Hannah E Botkin, et al.
Plos One
|
March 12, 2019
Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma
Katelynn Davis, Craig D Dunseth, Sarah L Mott, et al.
Journal of Lower Genital Tract Disease
|
September 4, 2020
Effect of Obesity on Cervical Cancer Screening and Outcomes
Colette M Gnade, Emily K Hill, Hannah E Botkin, et al.
Theranostics
|
September 15, 2018
Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness
Ying Xie, Yazhe Wang, Jing Li, et al.
Page
of 26